Patents by Inventor Grant R. Sutherland

Grant R. Sutherland has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Monoclonal and polyclonal antibodies relating to fragile X syndrome
    Patent number: 6242576
    Abstract: The DNA sequence spanning the fragile X site on the X human chromosome has been obtained in purified and isolated form. As fragile X is associated with mental retardation, the availability of a DNA which spans this locus permits diagnosis and treatment of the related mental disorders. Polyclonal and monoclonal antibodies to an amino acid sequence encoded by SEQ ID NO:1, a DNA sequence from the Fragile X site, are also disclosed.
    Type: Grant
    Filed: June 2, 1995
    Date of Patent: June 5, 2001
    Assignees: Women's and Children's Hospital, Washington University
    Inventors: Grant R. Sutherland, Robert I. Richards, David Schlessinger, Ramaiah Nagaraja, Eric J. Kremer, Sui Yu, Elizabeth Baker, John C. Mulley, Jean-Louis Mandel, Melanie April Pritchard, Michael Lynch
  • DNA sequences related to fragile X syndrome
    Patent number: 6197500
    Abstract: The DNA sequence spanning the fragile X site on the X human chromosome has been obtained in purified and isolated form. As fragile X is associated with mental retardation, the availability of a DNA which spans this locus permits diagnosis and treatment of the related mental disorders.
    Type: Grant
    Filed: September 9, 1993
    Date of Patent: March 6, 2001
    Assignee: Adelaide Medical Centre for Women and Children
    Inventors: Grant R. Sutherland, Robert I. Richards, David Schlessinger, Ramaiah Nagaraja, Eric J. Kremer, Sui Yu, Elizabeth Baker, John C. Mulley, Jean-Louis Mandel, Melanie April Pritchard, Michael Lynch